Skip to main content
. 2024 Jun 13;12(6):1315. doi: 10.3390/biomedicines12061315

Figure 4.

Figure 4

miR-21 2−ΔΔCt comparison (expression fold change) among the three groups. Legend: * p < 0.05; miR—miRNA; group 1—UC patients; group 2—CDI patients; group 3 (control group)—IBS-D patients.